Subsequent studies have demonstrated that CTLA-4 is a molecular component expressed on certain tumor cell lines at various degrees of intensity and can cause apoptosis of CTLA-4-expressing tumor cells after interaction with soluble CD80 or CD86 recombinant ligands [9]. The gene discussed is CD86; the disease is neoplasm.